Treace Medical Concepts (TMCI) Revenue (2020 - 2026)

Treace Medical Concepts' Revenue history runs 7 years deep, the most recent figure standing at $47.2 million for Q1 2026.

• Quarterly Revenue fell 10.22% year-over-year to $47.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $207.3 million (down 1.66% YoY) and the FY2025 annual result came in at $212.7 million, up 1.59% from the prior year.
• Revenue was $47.2 million for Q1 2026 at Treace Medical Concepts, down from $62.5 million in the prior quarter.
• Across five years, Revenue topped out at $68.7 million in Q4 2024 and bottomed at $29.0 million in Q1 2022.
• A 5-year average of $47.0 million and a median of $47.2 million in 2026 frame the typical range for Revenue.
• Annual changes were most pronounced in 2022 — Revenue jumped 55.27% — and 2026, when it fell 10.22%.
• Treace Medical Concepts' Revenue stood at $49.8 million in 2022, then climbed by 25.0% to $62.2 million in 2023, then climbed by 10.44% to $68.7 million in 2024, then retreated by 9.01% to $62.5 million in 2025, then fell by 24.51% to $47.2 million in 2026.
• Business Quant data shows TMCI's Revenue at $47.2 million in Q1 2026, $62.5 million in Q4 2025, and $50.2 million in Q3 2025.